EUVIMEDEUVIMED entdecken
Crossref

A Light‐Activatable Nitric Oxide Donor for Targeted Glaucoma Therapy with Real‐Time Monitoring Capabilities

Jiamin Liu, Yankun Lu, Yi Tian, Qian Liu, Xinghua Sun, Yi Liu, Yuan Lei iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202404221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Jiamin Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, NHC Key Laboratory of Myopia and Related Eye Diseases, Key Labor…. Hauptthemen laut MEDLINE: Nitric Oxide Donors, Light, Glaucoma, Open-Angle. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, General project of Shanghai Natural Science Foundation, Medical Engineering Joint Fund of Fudan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary open‐angle glaucoma (POAG), the most common form of glaucoma, is characterized by a gradual increase in intraocular pressure (IOP). Nitric oxide (NO) donors are promising treatments for POAG, but their effectiveness requires selective NO release triggered by ocular‐relevant stimuli. RhNO‐Ab, a visible light‐activatable NO donor and fluorescent probe is introduced. RhNO‐Ab releases NO from its N‐nitroso group and transforms from a non‐fluorescent spirolactone to fluorescent Rhodamine (Rh) upon NO release. In vitro studies, including in bulk and single molecule level demonstrated a rapid NO release and fluorescence recovery upon light irradiation. Immunofluorescence shows enhanced delivery to target tissues of RhNO‐Ab with ABCA1 antibody modification. Administration of RhNO‐Ab with light at 30, 20, and 10 µ m significantly reduces IOP in NOS3 KO mice by 2.11 mmHg (12.50%, n = 6), 1.77 mmHg (9.88%, n = 6), and 1.55 mmHg (8.23%, n = 6) 3 h post‐treatment ( * p < 0.05). RhNO‐Ab with light also reduces transendothelial electrical resistance (TEER) in Schlemm's canal (SC) endothelial cells (n = 3, * p < 0.05) and upregulates soluble guanylate cyclase (sGC) mRNA and protein expression in mouse outflow tissues and human trabecular meshwork (HTM) cells. Unlike traditional NO donors, RhNO‐Ab offers visible light‐triggered therapeutic NO release and real‐time monitoring, making it a promising novel strategy for POAG treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitric Oxide DonorsLightGlaucoma, Open-AngleAnimalsHumansNitric OxideMiceMice, KnockoutIntraocular PressureNitric Oxide Synthase Type III

Stichwörter der Autor:innen

NO donorintraocular pressureprimary open‐angle glaucomarhodaminevisible light‐activatable

Substanzen

Nitric Oxide DonorsNitric OxideNitric Oxide Synthase Type III

Autor:innen und Institutionen

  • Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, NHC Key Laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical S…
  • Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198, China.
  • Department of Chemistry and Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, Fudan University, Shanghai, 200438, China.

ORCID-Profile: Yuan Lei

Förderung

  • National Natural Science Foundation of China
  • General project of Shanghai Natural Science Foundation
  • Medical Engineering Joint Fund of Fudan University

Zitieren

APA

Liu, J., Lu, Y., Tian, Y., Liu, Q., Sun, X., Liu, Y., & Lei, Y. (2025). A Light‐Activatable Nitric Oxide Donor for Targeted Glaucoma Therapy with Real‐Time Monitoring Capabilities. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404221

Vancouver

Liu J, Lu Y, Tian Y, Liu Q, Sun X, Liu Y, et al. A Light‐Activatable Nitric Oxide Donor for Targeted Glaucoma Therapy with Real‐Time Monitoring Capabilities. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404221

BibTeX
@article{Liu2025,
  author = {Liu, Jiamin and Lu, Yankun and Tian, Yi and Liu, Qian and Sun, Xinghua and Liu, Yi and Lei, Yuan},
  title = {A Light‐Activatable Nitric Oxide Donor for Targeted Glaucoma Therapy with Real‐Time Monitoring Capabilities},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202404221}
}
Kostenlos starten →